AI Nose integration positions robotics application as a scalable growth engine Mirle partnership expands SmellTech robotics into industrial environments HOUSTON, TEXAS / ACCESS Newswire / February 5, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a SmellTech platform company digitizing scent as a native data language for artificial intelligence, today announced that Water Tower Research ("WTR") has published a report highlighting Ainos' expanding robotics opportunity and its stra ...

Core Insights - Ainos, Inc. has partnered with Mirle Automation Corporation to integrate its AI Nose platform into robotic systems, enabling machines to detect and interpret environmental signals through scent [1] - The partnership aims to enhance robotic capabilities in various applications, including semiconductor manufacturing, automated facilities, and safety monitoring [1] - Ainos' AI Nose digitizes scent into machine-readable data, addressing limitations of traditional sensory modalities like vision and audio [1] Company Overview - Ainos, Inc. is a dual-platform AI and biotech company focused on smell technology and immune therapeutics, with its AI Nose platform designed to support intelligent sensing across multiple sectors [1] - The AI Nose platform utilizes high-precision MEMS sensor arrays and proprietary AI algorithms for scent detection, converting analog signals into actionable data [1] - Ainos offers its technology under a SmellTech-as-a-Service model, providing ongoing access to scent intelligence and analytics [1] Partnership Details - The collaboration with Mirle Automation aims to deploy Ainos' AI Nose in mobile and quadruped robotic platforms for real-world applications [1] - Mirle Automation is recognized for its expertise in automation and robotics, providing a strong foundation for scaling advanced sensing technologies [1] - The integration of scent intelligence is expected to improve robotic safety, inspection efficiency, and situational awareness in complex environments [1]

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - Murano Global Investments Plc (MRNO) is up 146% at $3.35 [3] - Kustom Entertainment, Inc. (KUST) is up 34% at $2.84 [3] - Ainos, Inc. (AIMD) is up 34% at $2.32 [3] - Stride, Inc. (LRN) is up 29% at $94.10 [3] - Shuttle Pharmaceuticals Holdings, Inc. (SHPH) is up 18% at $2.40 [3] - Battalion Oil Corporation (BATL) is up 16% at $3.83 [3] - C3.ai, Inc. (AI) is up 15% at $14.58 [3] - Lantronix, Inc. (LTRX) is up 14% at $7.87 [3] - Nextpower Inc. (NXT) is up 13% at $120.00 [3] - High Roller Technologies, Inc. (ROLR) is up 7% at $7.56 [3] Premarket Losers - Flora Growth Corp. (FLGC) is down 34% at $7.20 [4] - TEN Holdings, Inc. (XHLD) is down 29% at $2.47 [4] - Global Interactive Technologies, Inc. (GITS) is down 22% at $3.25 [4] - 5E Advanced Materials, Inc. (FEAM) is down 15% at $2.70 [4] - Vyome Holdings, Inc. (HIND) is down 14% at $2.79 [4] - Altimmune, Inc. (ALT) is down 11% at $5.48 [4] - BiomX Inc. (PHGE) is down 10% at $6.22 [4] - Qorvo, Inc. (QRVO) is down 9% at $74.94 [4] - Nuwellis, Inc. (NUWE) is down 9% at $3.45 [4] - Brenmiller Energy Ltd (BNRG) is down 9% at $2.90 [4]

Ainos Fireside Chat Summary Company Overview - **Company**: Ainos (NasdaqCM:AIMD) - **Industry**: AI technology, specifically focusing on AI perception through smell Core Insights and Arguments - **Emerging AI Platform**: Ainos is positioned as an emerging AI perception platform that enables machines to understand smell, a fundamental human sense that has been largely overlooked in AI development [3][4] - **Smell as a New Input**: The company is developing a standardized format called Smell ID, which allows AI to learn from scent data, enhancing its ability to understand the physical environment [4][5] - **Platform vs. Product**: Ainos differentiates itself as a trainable platform rather than a static detection system, allowing continuous learning and scalability across different environments [6][10] - **Healthcare Foundation**: The initial focus on healthcare applications, such as pneumonia and women's health, has provided a strong foundation for expanding into industrial environments [10][11] Industrial Expansion - **Targeting Industrial Environments**: Ainos is expanding into industrial settings like semiconductor manufacturing, where continuous operations generate large amounts of scent data, making it an ideal environment for their technology [11][12] - **Commercial Traction**: Ainos has secured a multi-year order worth approximately $2.1 million for 1,400 units from a leading back-end semiconductor player, validating the platform's commercial potential [12][14] - **Partnerships**: Collaborations with companies like Trusval and Topco Scientific enhance Ainos's access to front-end semiconductor customers, facilitating entry into complex fab environments [16][18] Robotics Integration - **Focus on Robotics**: Ainos sees robotics as a key area for growth in 2026, aiming to enhance robots' capabilities by integrating scent perception, which can improve inspection, safety, and environmental monitoring [20][21] - **Pilot Programs**: Ongoing pilot programs with a Japanese robot developer indicate Ainos's commitment to expanding its technology into the robotics sector [21] Future Outlook - **Execution and Scaling**: Ainos is beginning light deployments in early 2026, marking the start of significant scaling efforts across industrial and robotics environments [22][24] - **Long-term Opportunities**: The company believes that its platform will enable smarter decision-making across various sectors, positioning Ainos and its subsidiary ScentAI for long-term growth [24] Additional Important Points - **Data Flywheel Effect**: As Ainos generates more Smell ID data, it strengthens the platform's capabilities, creating a compounding effect as it scales [23] - **Market Positioning**: Ainos aims to become a gatekeeper of real-world smell data, supporting a scalable subscription-based model [8] This summary encapsulates the key points discussed during the Ainos Fireside Chat, highlighting the company's innovative approach to AI perception through smell and its strategic expansion into industrial and robotics sectors.

HOUSTON, TEXAS / ACCESS Newswire / January 20, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a SmellTech platform company digitizing scent as a native data language for artificial intelligence, today announced that it will participate in a fireside chat with Robert Sassoon, senior research analyst at Water Tower Research, on Monday, January 26, 2026, at 11:00 a.m. ET. Ainos will discuss its dual-engine SmellTech platform strategy, the strategic benefits of its partnership with T ...

Partnership Supports Ainos' 2026 Strategic Focus on Advancing AI Nose Upstream and Accelerating Scent Data Accumulation in Advanced Wafer Fabs HOUSTON, TX / ACCESS Newswire / January 7, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW), a SmellTech platform company digitizing scent as a native data language for artificial intelligence, today announced that it has entered into a distribution and deployment agreement with Trusval Technology, a Taiwan-based engineering and technical services provider specializing ...

Core Insights - Ainos, Inc. is implementing a long-term strategy to digitize smell as a data language for AI, recognizing the opportunity in transforming one of the last major human senses into a structured format [2][4] - The company has developed a dual-engine platform architecture, separating sensing hardware from AI intelligence to enhance scalability and long-term value creation [4][5] Group 1: Platform Strategy - Ainos aims to create a layered SmellTech platform, AI Nose, which integrates sensing hardware and AI capabilities to ensure data consistency and scalability [3][4] - The separation of roles between Ainos and its subsidiary ScentAI allows for focused development in sensing and AI, reducing operational friction and clarifying governance [5] Group 2: Smell Language Model (SLM) - ScentAI is tasked with developing the Smell Language Model (SLM), which will classify and contextualize scent data, enabling it to be used as a scalable AI-native data asset [6] - The SLM is expected to facilitate monetization through enterprise APIs, SaaS offerings, and model licensing, while Ainos retains ownership of core datasets [6] Group 3: 2026 Execution Priorities - In 2026, Ainos will focus on deploying its technology in advanced semiconductor manufacturing and robotic applications, which require high precision and reliability [7] - These initial applications are seen as a strong entry point into the industrial market, with plans for broader deployment as the platform scales [7] Group 4: Long-Term Value Creation - As deployments of the AI Nose platform expand, the volume of scent data will increase, enhancing the Smell Language Model and creating a feedback loop that supports recurring revenue streams [8] - Ainos maintains control over the sensing layer, which is crucial for the platform's integrity and long-term success [8]

Revenue Performance - Ainos reported revenues of $2,167 in Q3 2025, a significant increase from nil in Q3 2024, attributed to sales of VELDONA pet supplements and pilot programs for the AI Nose platform [128][129]. - The company's revenue for the first nine months of 2025 was $113,037, a 445% increase from $20,729 in the same period of 2024 [140]. Gross Profit and Loss - Gross profit for Q3 2025 was $1,690, compared to a gross loss of $547 in Q3 2024, driven by increased sales volume [130]. - Gross profit for the first nine months of 2025 was $93,390, compared to a gross loss of $31,945 in the first nine months of 2024, reflecting a $125,335 improvement [143]. Expenses - Research and development (R&D) expenses were $1,990,630 in Q3 2025, a slight decrease of 2% from $2,022,244 in Q3 2024, due to reduced co-research expenses [131]. - Research and development expenses decreased by $459,134 (8%) to $5,626,514 in the first nine months of 2025 from $6,085,648 in the first nine months of 2024 [144]. - Selling, general and administrative (SG&A) expenses decreased by 22% to $795,253 in Q3 2025 from $1,015,758 in Q3 2024, primarily due to lower share-based compensation and reduced fees [134]. - Selling, general and administrative expenses increased by $1,069,571 (35%) to $4,159,627 in the first nine months of 2025 compared to $3,090,056 in the first nine months of 2024 [146]. Operating and Net Loss - Operating loss for the first nine months of 2025 was $9,692,751, a 5% increase from $9,207,649 in the first nine months of 2024 [148]. - Net loss for the first nine months of 2025 was $10,302,714, representing a 1% increase from $10,209,149 in the same period of 2024 [150]. Cash Position - As of September 30, 2025, Ainos had cash and cash equivalents of $1,128,217, with plans to fund operations through business revenues and external financing [123]. - Available cash as of September 30, 2025, was $1,128,217, down from $3,892,919 as of December 31, 2024 [151]. - Cash used in operating activities decreased by $1,184,357 to $3,759,679 in the first nine months of 2025 compared to $4,944,036 in the first nine months of 2024 [153]. Future Plans and Developments - Ainos plans to enter commercial pilot phase for the AI Nose platform across industrial, robotics, and long-term care environments in the second half of 2025 [107]. - The HIV oral wart program under the VELDONA platform has received Orphan Drug Designation from the U.S. FDA, with clinical trials planned in Taiwan [117]. - Ainos signed a three-year subscription-based order valued at $2.1 million with ASE Technology Holding Co., Ltd. for deploying 1,400 AI Nose units across three manufacturing sites [111]. - The company anticipates funding operations over the next twelve months through cash reserves, business revenues, and potential debt financing [155]. Other Notable Changes - Ainos has ceased selling COVID-19 antigen test kits as of Q1 2024, focusing on advancing its AI Nose and VELDONA platforms [119]. - Interest expense for the first nine months of 2025 was $534,986, an increase of 24% from $432,097 in the same period of 2024 [149].

Financial Performance - Ainos reported revenues of $2,167 for Q3 2025, compared to $0 in Q3 2024, and $113,037 for the nine months ended September 30, 2025, up from $20,729 in the same period last year[19]. - Total operating expenses decreased by 8% year over year to $2,785,883 in Q3 2025, driven by a 22% reduction in selling, general, and administrative expenses[5]. - The company incurred a net loss of $2,931,702 for Q3 2025, compared to a net loss of $3,699,317 in Q3 2024, and a total net loss of $10,302,714 for the nine months ended September 30, 2025, compared to $10,209,149 in the same period last year[19]. Intellectual Property and Innovation - Ainos has secured seven new patents, bringing its total to 123 active patents across key technologies, reinforcing its intellectual property leadership[8]. - The company launched its first commercial portable, cloud-connected AI Nose module designed for industrial and healthcare use on August 14, 2025[11]. Market and Strategic Partnerships - Ainos has expanded its partner ecosystem to six strategic partners in the semiconductor and industrial edge AI sectors, enhancing its market position[4]. - Ainos announced a strategic partnership with NEXCOM International to integrate AI Nose technology into industrial edge computing platforms, enhancing real-time environmental sensing[7]. - The global electronic-nose market is projected to grow from approximately $45 billion in 2025 to over $130 billion by 2034, representing a 12.7% compound annual growth rate[4]. Business Model and Classification - The company reclassified under the Global Industry Classification Standard to Technology Hardware, Storage & Peripherals, reflecting its transition to digital olfaction[7]. - Ainos aims to turn years of research into recurring, data-driven value through its SmellTech-as-a-Service model, enhancing safety and efficiency across various applications[4].

Core Insights - Ainos, Inc. has formed a strategic partnership with NEXCOM International Co., Ltd. to enhance its AI-powered scent digitization technology [1] - The collaboration aims to tap into the approximately $60 billion edge AI market, which is expected to expand global industrial channels [1] - The partnership is set to accelerate the commercialization of Ainos' AI Nose technology, contributing to advancements in intelligent sensing and industrial sustainability [1] Company Overview - Ainos, Inc. is recognized as a leader in AI-powered scent digitization [1] - NEXCOM International Co., Ltd. is a Taiwan-based pioneer in industrial computing and edge AI solutions [1] Market Potential - The partnership targets the edge AI market, valued at around $60 billion, indicating significant growth opportunities [1] - The collaboration is expected to enhance the reach and application of AI Nose technology across various industrial sectors [1]